193 related articles for article (PubMed ID: 1730782)
1. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
Hauguel-DeMouzon S; Csermely P; Zoppini G; Kahn CR
J Cell Physiol; 1992 Jan; 150(1):180-7. PubMed ID: 1730782
[TBL] [Abstract][Full Text] [Related]
2. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
Donato NJ; Ince C; Rosenblum MG; Gallick GE
J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
[TBL] [Abstract][Full Text] [Related]
3. 2-Aminopurine abolishes EGF- and TPA-stimulated pp33 phosphorylation and c-fos induction without affecting the activation of protein kinase C.
Mahadevan LC; Wills AJ; Hirst EA; Rathjen PD; Heath JK
Oncogene; 1990 Mar; 5(3):327-35. PubMed ID: 2107492
[TBL] [Abstract][Full Text] [Related]
4. Bombesin induction of c-fos and c-myc proto-oncogenes in Swiss 3T3 cells: significance for the mitogenic response.
Rozengurt E; Sinnett-Smith JW
J Cell Physiol; 1987 May; 131(2):218-25. PubMed ID: 3108267
[TBL] [Abstract][Full Text] [Related]
5. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone attenuation of epidermal growth factor-induced mitogenesis.
Wiepz GJ; Houtman JC; Cha D; Bertics PJ
J Cell Physiol; 1997 Oct; 173(1):44-53. PubMed ID: 9326448
[TBL] [Abstract][Full Text] [Related]
7. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
Liu J; Spence MJ; Wallace PM; Forcier K; Hellström I; Vestal RE
Cell Growth Differ; 1997 Jun; 8(6):667-76. PubMed ID: 9186000
[TBL] [Abstract][Full Text] [Related]
8. Immediate early gene expression in dog thyrocytes in response to growth, proliferation, and differentiation stimuli.
Deleu S; Pirson I; Clermont F; Nakamura T; Dumont JE; Maenhaut C
J Cell Physiol; 1999 Nov; 181(2):342-54. PubMed ID: 10497313
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor-mediated phosphorylation and protooncogene induction in Madin-Darby canine kidney cells.
Hauguel-de Mouzon S; Kahn CR
Mol Endocrinol; 1991 Jan; 5(1):51-60. PubMed ID: 1708099
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
Major TC; Keiser JA
J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
Sunada H; Yu P; Peacock JS; Mendelsohn J
J Cell Physiol; 1990 Feb; 142(2):284-92. PubMed ID: 1689318
[TBL] [Abstract][Full Text] [Related]
12. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells.
Baptist M; Dumont JE; Roger PP
Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241
[TBL] [Abstract][Full Text] [Related]
13. Transient induction of c-fos and c-myc in an immediate consequence of growth factor stimulation.
Curran T; Bravo R; Müller R
Cancer Surv; 1985; 4(4):655-81. PubMed ID: 3939686
[TBL] [Abstract][Full Text] [Related]
14. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
Gulli LF; Palmer KC; Chen YQ; Reddy KB
Cell Growth Differ; 1996 Feb; 7(2):173-8. PubMed ID: 8822200
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
Nass SJ; Dickson RB
Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
[TBL] [Abstract][Full Text] [Related]
16. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory action of epiderstatin on EGF-stimulated growth of mouse epidermal. BALB/MK cells without direct effect on protein kinase activities.
Osada H; Kikuchi K; Makishima F; Isono K
Oncol Res; 1994; 6(1):11-7. PubMed ID: 7919547
[TBL] [Abstract][Full Text] [Related]
18. Alterations in EGF-dependent proliferative and phosphorylation events in squamous cell carcinoma cell lines by a tyrosine kinase inhibitor.
Brunton VG; Carlin S; Workman P
Anticancer Drug Des; 1994 Aug; 9(4):311-29. PubMed ID: 7916899
[TBL] [Abstract][Full Text] [Related]
19. Modulation of epidermal growth factor receptor activity and related responses by the 7-deazaguanine derivative, queuine.
Langgut W; Reisser T; Kersten H; Nishimura S
Oncogene; 1993 Nov; 8(11):3141-7. PubMed ID: 8414516
[TBL] [Abstract][Full Text] [Related]
20. Cell cycle progression proteins (cyclins), oncogene expression, and signal transduction during the proliferative response of human hepatocytes to hepatocyte growth factor.
Gómez-Lechón MJ; Guillén I; Ponsoda X; Fabra R; Trullenque R; Nakamura T; Castell JV
Hepatology; 1996 May; 23(5):1012-9. PubMed ID: 8621126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
